NFKB1 and breast carcinoma: Lymph node positive luminal B tumors were enriched in pathways related to cell proliferation, immune response and cytoskeletal changes such as enrichment of PIK3CA, MAP kinases, NF-κB factors and RHOA, pathways which play role in breast cancer progression [67,74,75,76].